...hoped to raise €75 million ($110 million). Existing investors Gilde Healthcare Partners; Van Herk Group; ING Corporate Investments...

...by Debiopharm Group . All existing investors participated, including Gilde Healthcare Partners; Van Herk Group; ING Corporate Investments...

...issues that have plagued cell therapy play TiGenix N.V. (Euronext:TIG), where he invested while at ING Corporate Investments...

...€5 million ($7.3 million) of shares at the offer price. Shareholders include Breedinvest; Gilde Healthcare; ING Corporate Investments...

...Appointed: Willy Duron, a director, as chairman; and Luc Van de Steen, investment director at ING Corporate Investments...